| (210) | Number of the EPO application | 19824223 |
| (220) | Filing date of the EPO application | 2019.11.29 |
| (80) | EPO patent specification publication (B) | EPB nr. 11/2024, 2024.03.13 |
| (110) | EPO patent number | 3886894 |
| (21) | Number of the application | e 2021 0955 |
| (71) | Name(s) of applicant(s), code of the country | Juno Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | GILLENWATER Heidi, US;
ALBERTSON Tina, US;
DUBOVSKY Jason A., US;
THORPE Jerill, US; |
| (73) | Name(s) of owner(s), code of the country | Juno Therapeutics, Inc., US; |
| (54) | Title of the invention | METHODS FOR DOSING AND TREATMENT OF B CELL MALIGNANCIES IN ADOPTIVE CELL THERAPY |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C12N 5/0783 (2010.01.01); C07K 14/05 (2006.01.01); A61K 35/17 (2015.01.01); A61K 39/00 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.11.30 |
| (30) | Priority | 201862774168 P, 2018.11.30, US; 201862774858 P, 2018.12.03, US; 201962847897 P, 2019.05.14, US; 201962854957 P, 2019.05.30, US; 201962931143 P, 2019.11.05, US |
| (86) | International application | PCT/US2019/063883, 2019.11.29 |
| (87) | International publication | WO 2020/113188, 2020.06.04 |